Global AIDS coordinator Goosby should serve as 'fierce advocate' for pediatric HIV/AIDS programs, letter to editor Says

"The details of President Obama's new global health initiative have left many concerned that the financing described does not reflect the commitment required to lead the United States' efforts in the global fight against HIV and AIDS," Jennifer Delaney, executive director of Global Action for Children, writes in a New York Times letter to the editor.

She adds that the Obama administration "needs to recognize that we cannot afford to scrimp on global health -- the cost of failure is too high. Our inaction threatens to forsake the more than 15 million children orphaned by AIDS, future parents and leaders of our world."

As Eric Goosby, the recently nominated Global AIDS Coordinator, "begins his work in Washington, he faces serious obstacles to securing the full financing Congress has authorized to combat HIV and AIDS -- the financing our moral obligations demand," Delaney writes. She concludes, "We expect Dr. Goosby to be a fierce advocate for lifesaving HIV/AIDS and children's programs. He can expect our tireless support in return" (Delaney, New York Times, 5/17).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response